Pediatric Autoimmune Disorders: Recognizing and Managing Symptoms in Children with Ayurveda

Pediatric Autoimmune Disorders: Treating with Ayurveda

Autoimmune disorders, conditions where the immune system mistakenly attacks healthy cells, are on the rise in children, affecting their physical and emotional well-being. Conditions like juvenile arthritis, pediatric Crohn’s disease, and Type 1 diabetes present unique challenges in pediatric care. Ayurveda offers a gentle, natural approach to treating pediatric autoimmune disorders by addressing underlying imbalances, supporting immune function, and promoting long-term wellness (Pole, 2013). At EliteAyurveda, our approach to pediatric autoimmune care focuses on personalized, age-appropriate treatments that align with Ayurvedic principles, aiming to restore balance and improve quality of life for children (Sharma & Chandola, 2011).

Ayurveda’s Perspective on Pediatric Autoimmune Disorders

In Ayurveda, autoimmune disorders are understood as imbalances in the body’s doshas—Vata, Pitta, and Kapha—combined with weakened Agni (digestive fire) and the accumulation of Ama (toxins) (Lad, 2002). Children have unique constitutions and sensitivities, so Ayurveda takes a gentle, supportive approach to address the specific needs of each child (Dass, 2013).

• Vata Imbalance: Vata governs movement and is sensitive to change. Vata-related autoimmune symptoms in children may manifest as joint pain, nervousness, and irregular sleep (Frawley, 2000).
• Pitta Imbalance: Pitta governs heat and metabolism, and its excess can cause inflammation, digestive issues, and irritability. Many pediatric autoimmune symptoms, such as inflammation and fever, reflect a Pitta imbalance (Pole, 2013).
• Kapha Imbalance: Kapha is associated with structure and immunity. Kapha-related autoimmune symptoms can include mucus buildup, sluggishness, and immune hypersensitivity, impacting respiratory health and energy (Mishra, 2004).

Ayurveda focuses on treating these imbalances, supporting a child’s growth and immunity, and managing symptoms naturally. EliteAyurveda tailors care to each child’s constitution, aiming to support long-term resilience and wellness (Sharma & Chandola, 2011).

Key Ayurvedic Principles for Treating Pediatric Autoimmune Disorders

When treating pediatric autoimmune conditions, Ayurveda emphasizes a gentle approach that addresses root imbalances, supports immune function, and reduces the triggers of inflammation. Here’s how Ayurveda views the core aspects of managing these conditions:

1. Agni (Digestive Fire) and Immunity

In Ayurveda, a strong Agni (digestive fire) is crucial for overall health and immunity. When Agni is weak, food is not fully digested, leading to the accumulation of Ama (toxins) that disrupts immune function and increases inflammation. This weakened digestion is often seen in pediatric autoimmune cases (Lad, 2002).

• Ayurvedic Insight: Strengthening Agni with gentle digestive herbs, easy-to-digest foods, and regular mealtimes helps improve nutrient absorption, detoxifies the body, and supports a balanced immune response (Frawley, 2000). EliteAyurveda’s approach emphasizes a diet that supports Agni without overburdening a child’s sensitive digestive system.

2. Balancing Doshas for Symptom Relief

Each dosha affects the body differently, and Ayurvedic care focuses on addressing the dominant doshic imbalance to alleviate symptoms and restore harmony (Pole, 2013).

• Vata-Pacifying Practices: For autoimmune symptoms with joint pain and sleep disturbances, calming Vata with warm, grounding foods and routines helps support physical comfort and emotional stability (Dass, 2013).
• Pitta-Reducing Measures: For inflammatory conditions, such as juvenile arthritis, cooling foods and gentle, anti-inflammatory herbs help soothe Pitta and reduce pain and swelling (Lad, 2002).
• Kapha-Balancing Adjustments: To manage respiratory symptoms or mucus buildup, light, warm foods and daily physical activity help prevent Kapha accumulation and improve energy levels (Mishra, 2004).

3. Reducing Ama (Toxins) Through Gentle Detoxification

Ama, or toxic buildup, can be especially challenging in pediatric autoimmune disorders. Unlike adults, children require very gentle detoxification to avoid stress on their systems. In Ayurveda, simple detox practices are used to reduce Ama and support immunity (Frawley, 2000).

• Ayurvedic Approach: Detoxification methods for children focus on supporting Agni through light, easily digestible meals, warm teas, and mild detoxifying herbs (Pole, 2013). At EliteAyurveda, we design personalized detox plans that align with each child’s constitution, helping eliminate toxins without disrupting their natural balance (Sharma & Chandola, 2011).

EliteAyurveda’s Holistic Approach to Pediatric Autoimmune Care

At EliteAyurveda, we approach pediatric autoimmune care with an understanding of children’s unique constitutions and developmental needs. Our treatments aim to nurture a child’s innate healing capacity, strengthen immunity, and provide relief from symptoms through safe, side-effect-free care (Dass, 2013).

1. Dietary Guidance for Immunity and Digestive Health

Diet is one of the most powerful tools in Ayurveda, especially for supporting children’s immunity and growth. EliteAyurveda provides age-appropriate dietary guidance that balances doshas, strengthens digestion, and minimizes inflammation (Lad, 2002).

• Kapha-Balancing Foods: Light, warm foods such as soups, rice, and steamed vegetables help avoid congestion and support clear channels, reducing Kapha-related immune imbalances (Mishra, 2004).
• Pitta-Pacifying Foods: Cooling, anti-inflammatory foods like cucumber, ghee, and apples help reduce inflammation and soothe Pitta-related symptoms (Frawley, 2000).
• Vata-Stabilizing Foods: Warm, grounding foods, including oats, carrots, and sweet potatoes, provide Vata stability and comfort, helping manage joint discomfort and nervousness (Dass, 2013).

2. Personalized, Side-Effect-Free Herbal Treatments

Our Ayurvedic herbal treatments are specifically tailored to suit children’s sensitivities, supporting immune health, calming inflammation, and balancing doshas without adverse effects. Herbs are selected based on the child’s constitution and specific needs (Pole, 2013).

• Targeted Herbal Support: For example, gentle, cooling herbs help reduce inflammation for Pitta-predominant children, while grounding herbs stabilize Vata. EliteAyurveda’s herbal formulations are designed to support the child’s unique requirements, fostering natural resilience and supporting immune function (Lad, 2002).

3. Establishing a Consistent Routine (Dinacharya) for Stability

A consistent daily routine, or Dinacharya, provides stability, improves digestion, and helps children cope with the unpredictability of autoimmune conditions (Frawley, 2000). Ayurveda emphasizes regular schedules to balance Vata, support Agni, and enhance immunity.

• Regular Sleep and Mealtimes: Consistent sleep and mealtimes help maintain Agni, balance doshas, and support overall resilience, which is especially important for children with autoimmune conditions (Pole, 2013).
• Abhyanga (Self-Oil Massage): Daily oil massage using warm, dosha-specific oils like sesame or coconut helps ground the child’s mind and body, providing comfort, enhancing circulation, and reducing dryness (Mishra, 2004).

4. Mind-Body Practices for Emotional Resilience

Living with an autoimmune condition can be emotionally challenging, even for children. Ayurveda emphasizes the connection between mind and body, incorporating mind-body practices to support mental and emotional well-being (Dass, 2013).

• Gentle Yoga and Breathwork: Age-appropriate yoga poses and breathing exercises help children feel calm, grounded, and emotionally resilient, balancing Vata and Pitta and helping to reduce stress (Frawley, 2000).
• Visualization and Meditation: Simple visualization exercises and short meditation practices can help children manage stress and foster a positive outlook, reducing the psychological toll of chronic illness (Sharma & Chandola, 2011).

The Long-Term Benefits of Ayurvedic Care for Pediatric Autoimmune Disorders

Ayurvedic care for pediatric autoimmune disorders provides sustainable, long-term benefits by addressing underlying imbalances, supporting immunity, and fostering emotional resilience. The holistic approach at EliteAyurveda benefits children with autoimmune conditions in multiple ways:

• Reduced Flare-Ups and Symptom Severity: By balancing doshas, strengthening Agni, and reducing Ama, Ayurveda minimizes the likelihood of flare-ups and reduces symptom severity (Lad, 2002).
• Enhanced Physical and Emotional Well-Being: Mind-body practices help children develop resilience, stay grounded, and reduce stress, improving their overall quality of life (Dass, 2013).
• Improved Immune Function: Ayurveda’s approach supports natural immunity, reducing dependency on medications and helping the child’s body respond to environmental stressors more effectively (Pole, 2013).

Why Choose EliteAyurveda for Pediatric Autoimmune Care?

At EliteAyurveda, we understand that treating pediatric autoimmune conditions requires a compassionate, individualized approach that is sensitive to each child’s constitution and needs (Sharma & Chandola, 2011). Our experienced practitioners design care plans that include side-effect-free herbs, personalized dietary guidance, gentle detoxification, and lifestyle recommendations to support the child’s holistic health. By focusing on root causes and promoting long-term resilience, we help children achieve lasting improvements in both physical and emotional well-being (Lad, 2002).

If you’re seeking a natural, Ayurvedic approach to pediatric autoimmune care, EliteAyurveda provides expert guidance and support tailored to your child’s unique needs (EliteAyurveda, n.d.).

---

---

Related-

Know More Ayurveda Treatments For Autoimmune Conditions.

GET IN TOUCH

Schedule a Visit

Contact us

---

References

1.Pituch-Noworolska A, Mach-Tomalska M. Autoimmunity of gastrointestinal tract immunopathogenesis and immune-based therapy for selected autoimmune disorders. Mourad Aribi, ed. Intech Open March 22nd 2017. https://doi.org/10.5772/63032 10.5772/63032 [DOI] [Google Scholar]

2.Cojocaru M, Cojocaru IM, Silosi I, et al. Gastrointestinal manifestations in systemic autoimmune diseases. Maedica (Bucur) 2011;6:45-51. [PMC free article] [PubMed] [Google Scholar]

3.Unsworth DJ, Walker-Smith JA. Autoimmunity in diarrhoeal disease. J Pediatr Gastroenterol Nutr 1985;4:375-380. https://doi.org/10.1097/00005176-198506000-00009 10.1097/00005176-198506000-00009 [DOI] [PubMed] [Google Scholar]

4.Ensari A, Kelsen J, Russo P. Newcomers in paediatric GI pathology: childhood enteropathies including very early onset monogenic IBD. Virchows Arch 2018;472:111-123. https://doi.org/10.1007/s00428-017-2197-9 10.1007/s00428-017-2197-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

5.Rossi C, Simoncelli G, Arpa G, et al. Histopathology of intestinal villi in neonatal and paediatric age: main features with clinical correlation Part I. Pathologica 2021. Epub December 2. https://doi.org/10.32074/1591-951X-337 10.32074/1591-951X-337 [DOI] [PMC free article] [PubMed] [Google Scholar]

6.Russo PA, Brochu P, Seidman EG, et al. Autoimmune enteropathy. Pediatr Dev Pathol 1999;2:65-71. https://doi.org/10.1007/s100249900092 10.1007/s100249900092 [DOI] [PubMed] [Google Scholar]

7.Walker-Smith JA, Unsworth DJ, Hutchins P, et al. Autoantibodies against gut epithelium in child with small-intestinal enteropathy. Lancet 1982;1(8271):566-7. https://doi.org/10.1016/s0140-6736(82)92076-1 10.1016/s0140-6736(82)92076-1 [DOI] [PubMed] [Google Scholar]

8.Skogh T, Heuman R, Tagesson C. Anti- brush border antibodies (ABBA) in Crohn’s disease. J Clin Lab Immunol 1982;9:147-150. [PubMed] [Google Scholar]

9.Montalto M, D’Onofrio F, Santoro L, et al. Autoimmune enteropathy in children and adults. Scand J Gastroenterol 2009;44:1029-1036. https://doi.org/10.1080/00365520902783691 10.1080/00365520902783691 [DOI] [PubMed] [Google Scholar]

10.Chen CB, Tahboub F, Plesec T, et al. A Review of autoimmune enteropathy and its associated syndromes. Dig Dis Sci 2020;65:3079-3090. https://doi.org/10.1007/s10620-020-06540-8 10.1007/s10620-020-06540-8 [DOI] [PubMed] [Google Scholar]

11.Parente P, Pastore M, Grillo F, et al. Very Early Onset-IBD: evidence for the need of a multidisciplinary approach. Pathologica 2021. Epub December 2. https://doi.org/10.32074/1591-951X-336 10.32074/1591-951X-336 [DOI] [PMC free article] [PubMed] [Google Scholar]

12.Rossi C, Simoncelli G, Arpa G, et al. Histopathology of intestinal villi in neonatal and paediatric age: main features with clinical correlation Part II. Pathologica 2021. Epub December 2. https://doi.org/10.32074/1591-951X-338 10.32074/1591-951X-338 [DOI] [PMC free article] [PubMed] [Google Scholar]

13.Biagi F, Bianchi PI, Trotta L, et al. Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy? Am J Gastroenterol 2009;104:3112. https://doi.org/10.1038/ajg.2009.511 10.1038/ajg.2009.511 [DOI] [PubMed] [Google Scholar]

14.Elkon K, Casali P. Nature and functions of autoantibodies. Nat Clin Pract Rheumatol 2008;4:491-498. https://doi.org/10.1038/ncprheum0895 10.1038/ncprheum0895 [DOI] [PMC free article] [PubMed] [Google Scholar]

15.Patey-Mariaud de Serre N, Canioni D, Ganousse S, Rieux-Laucat F, Goulet O, Ruemmele F, Brousse N. Digestive histopathological presentation of IPEX syndrome. Mod Pathol 2009;22:95-102. https://doi.org/10.1038/modpathol.2008.161 10.1038/modpathol.2008.161 [DOI] [PubMed] [Google Scholar]

16.Zhang X, Olsen N, Zheng SG. The progress and prospect of regulatory T cells in autoimmune diseases. J Autoimmun 2020;111:102461. https://doi.org/10.1016/j.jaut.2020.102461 10.1016/j.jaut.2020.102461 [DOI] [PubMed] [Google Scholar]

17.Otsubo K, Kanegane H, Kamachi Y, et al. Identification of FOXP3-negative regulatory T-like (CD4(+) CD25(+) CD127(low)) cells in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Clin Immunol 2011;141:111-120. https://doi.org/10.1016/j.clim.2011.06.006 10.1016/j.clim.2011.06.006 [DOI] [PubMed] [Google Scholar]

18.Gambineri E, Ciullini Mannurita S, et al. Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, x-linked (IPEX) syndrome. Front Immunol 2018;9:2411. https://doi.org/10.3389/fimmu.2018.02411 10.3389/fimmu.2018.02411 [DOI] [PMC free article] [PubMed] [Google Scholar]

19.Van Gool F, Nguyen MLT, Mumbach MR, et al. A mutation in the transcription factor Foxp3 drives T helper 2 effector function in regulatory T cells. Immunity 2019;50:362-377. e6. https://doi.org/10.1016/j.immuni.2018.12.016 10.1016/j.immuni.2018.12.016 [DOI] [PMC free article] [PubMed] [Google Scholar]

20.Kinnunen T, Chamberlain N, Morbach H, et al. Accumulation of peripheral autoreactive B cells in the absence of functional human regulatory T cells. Blood 2013;121:1595-1603. https://doi.org/10.1182/blood-2012-09-457465 10.1182/blood-2012-09-457465 [DOI] [PMC free article] [PubMed] [Google Scholar]

21.Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 2002;31:295-320, vi. https://doi.org/10.1016/s0889-8529(01)000135 10.1016/s0889-8529(01)000135 [DOI] [PubMed] [Google Scholar]

22.Kisand K, Peterson P. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome: APECED: known and novel aspects of the syndrome. Ann NY Acad Sci 2011;1246:77-91. https://doi.org/10.1111/j.1749-6632.2011.06308.x 10.1111/j.1749-6632.2011.06308.x [DOI] [PubMed] [Google Scholar]

23.Yang S, Fujikad N, Kolodin D, et al. Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science 2015;348:589-594. https://doi.org/10.1126/science.aaa7017 10.1126/science.aaa7017 [DOI] [PMC free article] [PubMed] [Google Scholar]

24.Singhi AD, Goyal A, Davison JM, et al. Pediatric autoimmune enteropathy: an entity frequently associated with immunodeficiency disorders. Mod Pathol 2014;27:543-553. https://doi.org/10.1038/modpathol.2013.150 10.1038/modpathol.2013.150 [DOI] [PubMed] [Google Scholar]

25.Wosen JE, Mukhopadhyay D, Macaubas C, et al. Epithelial MHC class II expression and its role in antigen presentation in the gastrointestinal and respiratory tracts. Front Immunol 2018;9:2144. https://doi.org/10.3389/fimmu.2018.02144 10.3389/fimmu.2018.02144 [DOI] [PMC free article] [PubMed] [Google Scholar]

26.Sanderson IR, Phillips AS, Spencer J, et al. Response to autoimmune enteropathy to cyclosporin A therapy. Gut 1991;32:1421-1425. https://doi.org/10.1136/gut.32.11.1421 10.1136/gut.32.11.1421 [DOI] [PMC free article] [PubMed] [Google Scholar]

27.Kobayashi I, Imamura K, Yamada M, et al. A 75-kD autoantigen recognized by sera from patients with X-linked autoimmune enteropathy associated with nephropathy. Clin Exp Immunol 1998;111:527-531. https://doi.org/10.1046/j.1365-2249.1998.00523.x 10.1046/j.1365-2249.1998.00523.x [DOI] [PMC free article] [PubMed] [Google Scholar]

28.Savage MO, Mirakian R, Wozniak ER, et al. Specific autoantibodies to gut epithelium in two infants with severe protracted diarrhoea. J Pediatr Gastroenterol Nutr 1985;4:187-195. https://doi.org/10.1097/00005176-198504000-00006 10.1097/00005176-198504000-00006 [DOI] [PubMed] [Google Scholar]